Phoenix Cardiac Devices, Inc.
Next generation medical device to treat mitral regurgitation without open heart surgery and with flexibility to adjust post implantation.
Mitral Regurgitation affects ~2% of the global population. Current standard of care requires open heart surgery to repair or replace the mitral valve. BACE device does not require open heart surgery because it sits outside of and around the heart. The device can also be adjusted post-op by a cardiologist in an out-patient setting to maintain efficacy. "No open heart surgery" and "post-op adjustability" are the key benefits.